Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial

Published:2019-11 Issue:11 Volume:6 Page:e737-e749
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Pantaleo Giuseppe,Janes Holly,Karuna Shelly,Grant Shannon,Ouedraogo G Laissa,Allen Mary,Tomaras Georgia D,Frahm Nicole,Montefiori David C,Ferrari Guido,Ding Song,Lee Carter,Robb Merlin L,Esteban Mariano,Wagner Ralf,Bart Pierre-Alexandre,Rettby Nils,McElrath M Juliana,Gilbert Peter B,Kublin James G,Corey Lawrence

Funder

US Public Health Service

Bill & Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference36 articles.

1. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection;Flynn;J Infect Dis,2005

2. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand;Pitisuttithum;J Infect Dis,2006

3. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial;Buchbinder;Lancet,2008

4. Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study;Gray;Lancet Infect Dis,2011

5. Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study);Duerr;J Infect Dis,2012

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA vaccine prime and replicating vaccinia vaccine boost induce robust humoral and cellular immune responses against MERS-CoV in mice;Virologica Sinica;2024-06

2. Safety and immunogenicity of a DNA vaccine with subtype C gp120 protein adjuvanted with MF59® or AS01B: a phase 1/2a HIV-1 vaccine trial;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-05-03

3. DNA and protein HIV vaccines: how should we mix it?;The Lancet HIV;2024-05

4. Safety and immunogenicity of a polyvalent DNA–protein HIV vaccine with matched Env immunogens delivered as a prime–boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial;The Lancet HIV;2024-05

5. The Question of HIV Vaccine: Why Is a Solution Not Yet Available?;Journal of Immunology Research;2024-04-08